Coronavirus disease 2019 transmission and symptoms in young children during the severe acute respiratory syndrome coronavirus 2 Delta variant and Omicron variant outbreaks
- PMID: 35619217
- PMCID: PMC9150257
- DOI: 10.1177/03000605221102079
Coronavirus disease 2019 transmission and symptoms in young children during the severe acute respiratory syndrome coronavirus 2 Delta variant and Omicron variant outbreaks
Abstract
Objective: Little is known about the transmission of coronavirus disease 2019 (COVID-19) in young children. This study aimed to clarify the risk of COVID-19 transmission among this population.
Methods: Between July 2020 and April 2022, 1660 0 to 3-year-old children underwent a nasopharyngeal swab for later reverse transcription-polymerase chain reaction testing at a mass screening test center in Japan. Their disease transmission rate and clinical symptoms were evaluated according to the predominant variant strains of that season.
Results: The secondary transmission rate after close contact of the Delta B.1.617.2 (17.4%) and Omicron B.1.1.529 (39.2%) variants was significantly higher than that of the conventional strains (B.1.1.284 and B.1.1.214; 4.5%) during the pandemic. The increased transmissibility with the Delta and Omicron variants was independent of close contact or location. The prevalence rates of cough, fatigability, and fever were similar in young children infected by the Delta and Omicron variants.
Conclusions: COVID-19 transmission in children aged 0 to 3 years increased by 3 to 4 fold during the Delta outbreak and by 8 to 10 fold during the Omicron outbreak compared with the conventional strain outbreak. The symptoms in young children were not different between the Delta and Omicron variants.
Keywords: Coronavirus disease 2019; Delta; Omicron; symptom; transmission; variant strain; young child.
Conflict of interest statement
Figures

Similar articles
-
COVID-19-Related Symptoms during the SARS-CoV-2 Omicron (B.1.1.529) Variant Surge in Japan.Tohoku J Exp Med. 2022 Sep 6;258(2):103-110. doi: 10.1620/tjem.2022.J067. Epub 2022 Aug 25. Tohoku J Exp Med. 2022. PMID: 36002251
-
Comparison of epidemiological characteristics and transmissibility of different strains of COVID-19 based on the incidence data of all local outbreaks in China as of March 1, 2022.Front Public Health. 2022 Sep 15;10:949594. doi: 10.3389/fpubh.2022.949594. eCollection 2022. Front Public Health. 2022. PMID: 36187650 Free PMC article.
-
Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.Front Public Health. 2023 Apr 27;11:1149795. doi: 10.3389/fpubh.2023.1149795. eCollection 2023. Front Public Health. 2023. PMID: 37181688 Free PMC article.
-
Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?Int J Environ Res Public Health. 2022 Apr 11;19(8):4586. doi: 10.3390/ijerph19084586. Int J Environ Res Public Health. 2022. PMID: 35457468 Free PMC article. Review.
-
SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era.Virol J. 2022 Sep 8;19(1):144. doi: 10.1186/s12985-022-01873-4. Virol J. 2022. PMID: 36076271 Free PMC article. Review.
Cited by
-
Comparison of Omicron and Delta Variants of SARS-CoV-2: A Systematic Review of Current Evidence.Infect Disord Drug Targets. 2024;24(7):e050324227686. doi: 10.2174/0118715265279242240216114548. Infect Disord Drug Targets. 2024. PMID: 38445691
-
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.N Engl J Med. 2023 Feb 16;388(7):621-634. doi: 10.1056/NEJMoa2211031. N Engl J Med. 2023. PMID: 36791162 Free PMC article. Clinical Trial.
-
Risk of COVID-19 in Children throughout the Pandemic and the Role of Vaccination: A Narrative Review.Vaccines (Basel). 2024 Aug 29;12(9):989. doi: 10.3390/vaccines12090989. Vaccines (Basel). 2024. PMID: 39340021 Free PMC article. Review.
-
Parents' attitudes toward childhood COVID-19 immunization in Croatia: a multicenter cross-sectional study.Croat Med J. 2023 Feb 28;64(1):52-60. doi: 10.3325/cmj.2023.64.52. Croat Med J. 2023. PMID: 36864819 Free PMC article.
-
The BNT162b2 vaccine induces humoral and cellular immune memory to SARS-CoV-2 Wuhan strain and the Omicron variant in children 5 to 11 years of age.Front Immunol. 2022 Dec 15;13:1094727. doi: 10.3389/fimmu.2022.1094727. eCollection 2022. Front Immunol. 2022. PMID: 36591287 Free PMC article.
References
-
- Reis G, Dos Santos Moreira-Silva EA, Silva DCM, et al.. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Glob Health 2022; 10: e42–e51. 20211028. DOI: 10.1016/s2214-109x(21)00448-4. - PMC - PubMed
-
- World Health Organization. Tracking SARS-CoV-2 variants, https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/.
-
- Song P, Karako T. The strategy behind Japan's response to COVID-19 from 2020–2021 and future challenges posed by the uncertainty of the Omicron variant in 2022. Biosci Trends 2022; 15: 350–352. 20211228. DOI: 10.5582/bst.2021.01560. - PubMed
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous